NEWTYN MANAGEMENT, LLC – Merrimack Pharmaceuticals, Inc. Transaction History
NEWTYN MANAGEMENT, LLC portfolio value:
$6.62M
portfolio value
NEWTYN MANAGEMENT, LLC quarter portfolio value change:
-36.97%
quarter
Merrimack Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.52% | 9.08K shares | -3.83M | $3.75 | 1.76M |
| Q2 2022 | share | Increase | +2.59% | 44.39K shares | -370K | $5.95 | 1.75M |
| Q1 2022 | share | Increase | +10.64% | 164.72K shares | 4.77M | $6.33 | 1.71M |
| Q4 2021 | share | 0.00% | 0 shares | -1.42M | $3.93 | 1.54M | |
| Q3 2021 | share | 0.00% | 0 shares | -2.38M | $4.83 | 1.54M | |
| Q2 2021 | share | 0.00% | 0 shares | 170K | $6.39 | 1.54M | |
| Q1 2021 | share | 0.00% | 0 shares | -976K | $6.28 | 1.54M | |
| Q4 2020 | share | Increase | +19.47% | 252.44K shares | 5.48M | $6.89 | 1.54M |
| Q3 2020 | share | Increase | +8.07% | 96.83K shares | 1.19M | $4 | 1.29M |
| Q2 2020 | share | Increase | +2.25% | 26.44K shares | 1.47M | $3.33 | 1.19M |
| Q1 2020 | share | 0.00% | 0 shares | -1.17M | $2.15 | 1.17M | |
| Q4 2019 | share | 0.00% | 0 shares | -1.57M | $3.15 | 1.17M | |
| Q3 2019 | share | Decrease | -23.85% | -367.47K shares | -2.06M | $3.98 | 1.17M |
| Q2 2019 | share | Increase | +5.90% | 85.87K shares | -622K | $3.32 | 1.54M |
| Q1 2019 | share | Increase | +28.80% | 325.32K shares | 4.52M | $3.82 | 1.45M |
| Q4 2018 | share | Increase | +31.65% | 271.51K shares | -168K | $2.12 | 1.12M |
| Q3 2018 | share | Increase | +6.58% | 53.00K shares | 489K | $2.93 | 857.92K |
| Q2 2018 | share | Increase | +349.60% | 625.89K shares | 1.97M | $2.7 | 804.92K |
| Q1 2018 | share | Decrease | -61.13% | -281.49K shares | -2.58M | $4.42 | 179.03K |
| Q4 2017 | share | Decrease | -7.09% | -35.16K shares | -1.95M | $5.63 | 460.52K |
| Q3 2017 | share | Increase | 0.00% | 495.69K shares | 5.67M | $7.98 | 495.69K |